Heat shock protein 70 chaperone overexpression ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model by reducing nuclear …

H Adachi, M Katsuno, M Minamiyama… - Journal of …, 2003 - Soc Neuroscience
H Adachi, M Katsuno, M Minamiyama, C Sang, G Pagoulatos, C Angelidis, M Kusakabe…
Journal of Neuroscience, 2003Soc Neuroscience
Spinal and bulbar muscular atrophy (SBMA) is an inherited motor neuron disease caused by
the expansion of the polyglutamine (polyQ) tract within the androgen receptor (AR). The
nuclear inclusions consisting of the mutant AR protein are characteristic and combine with
many components of ubiquitin–proteasome and molecular chaperone pathways, raising the
possibility that misfolding and altered degradation of mutant AR may be involved in the
pathogenesis. We have reported that the overexpression of heat shock protein (HSP) …
Spinal and bulbar muscular atrophy (SBMA) is an inherited motor neuron disease caused by the expansion of the polyglutamine (polyQ) tract within the androgen receptor (AR). The nuclear inclusions consisting of the mutant AR protein are characteristic and combine with many components of ubiquitin–proteasome and molecular chaperone pathways, raising the possibility that misfolding and altered degradation of mutant AR may be involved in the pathogenesis. We have reported that the overexpression of heat shock protein (HSP) chaperones reduces mutant AR aggregation and cell death in a neuronal cell model . To determine whether increasing the expression level of chaperone improves the phenotype in a mouse model, we cross-bred SBMA transgenic mice with mice overexpressing the inducible form of human HSP70. We demonstrated that high expression of HSP70 markedly ameliorated the motor function of the SBMA model mice. In double-transgenic mice, the nuclear-localized mutant AR protein, particularly that of the large complex form, was significantly reduced. Monomeric mutant AR was also reduced in amount by HSP70 overexpression, suggesting the enhanced degradation of mutant AR. These findings suggest that HSP70 overexpression ameliorates SBMA phenotypes in mice by reducing nuclear-localized mutant AR, probably caused by enhanced mutant AR degradation. Our study may provide the basis for the development of an HSP70-related therapy for SBMA and other polyQ diseases.
Soc Neuroscience